Adrianna Amaral
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adrianna Amaral has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Tamara Levin Lotan
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
88 shared publications - Angelo Michael De Marzo
Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University, School of Medicine Baltimore MD USA
86 shared publications - Corinne E. Joshu
Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA
83 shared publications - Jiayun Lu
Sidney Kimmel Comprehensive Cancer Center 1 Baltimore, Maryland
83 shared publications - Karen Sandell Sfanos
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
83 shared publications - Thiago Vidotto
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
83 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S4: DNA methylation in HLA Class I genes in PCa.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S4: DNA methylation in HLA Class I genes in PCa.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S2: DNA methylation in HLA Class I genes in benign and malignant prostate.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S2: DNA methylation in HLA Class I genes in benign and malignant prostate.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S13 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S13: HLA-I protein expression stratified by PTEN and transcriptional androgen receptor activity (AR-A) score.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S13 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S13: HLA-I protein expression stratified by PTEN and transcriptional androgen receptor activity (AR-A) score.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S6: HLA Class I expression in the pN1 Cohort.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S6: HLA Class I expression in the pN1 Cohort.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S5: Spearman correlation for HLA-I protein H-score and HLA-I gene methylation level. A, B, C.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S5: Spearman correlation for HLA-I protein H-score and HLA-I gene methylation level. A, B, C.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S8: DNA methylation in HLA Class I genes and PTEN status.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S8: DNA methylation in HLA Class I genes and PTEN status.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S7: HLA Class I expression and PTEN status.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S7: HLA Class I expression and PTEN status.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S9: DNA methylation in HLA Class I genes and PTEN status.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Figure S9: DNA methylation in HLA Class I genes and PTEN status.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Table S1. Probes Used for the Methylation Analysis.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Supplementary Table S1. Probes Used for the Methylation Analysis.